Georgia's Online Cancer Information Center

Sheryl Gabram-Mendola

Sheryl Gabram-Mendola, MD, MBA, FACS

Chief Scientific Officer

Sheryl Gabram-Mendola, MD, MBA, FACS

Sheryl Gabram-Mendola

Chief Scientific Officer

Sheryl is Professor Emerita of Surgery for Emory University and the Ada Lee Correll Chair Emerita, having retired from Emory after 15 years of service. Her research focused on decreasing disparities of breast cancer care through a community education outreach program and providing access to high quality care for breast cancer patients. As Chief Scientific Officer, Sheryl will serve as the principal investigator in connection with clinical studies and other research projects, as well as ensure compliance with grant administration. In her free time, she enjoys hiking with her daughter and husband in the north Georgia mountains and along South Carolina waterfalls. Contact her at sgabram@georgiacore.org.

About Us

Despite pandemic, Georgia’s Colorectal Cancer Control Program making significant strides

Thanks to funding awarded by the Centers for Disease Control for five-years beginning July 2020, Georgia CORE and Augusta University are partners in the Georgia Colorectal Cancer Control Program, which is increasing CRC screenings in southeast and southwest Georgia.

3/23/2021

Chasing Cancer with Otis Brawley, MD & Ezekiel J. Emanuel, MD

Otis Brawley says he thinks coronavirus vaccine should be mandated like other vaccines in the U.S.

8/03/2021

Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).

6/29/2021

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofitthat leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.